EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 41 (Novembre 2025) Hors série n° 2 Med Sci (Paris), 41 (2025) 6-13 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 41, Novembre 2025
Les Cahiers de Myologie
Page(s) 6 - 13
Section Mise au point
DOI https://doi.org/10.1051/medsci/2025169
Publié en ligne 28 novembre 2025
  1. DiMauro S, Schon EA, Carelli V, et al. The clinical maze of mitochondrial neurology. Nat Rev Neurol. 2013 ; 9 (8) : 429–44. [Google Scholar]
  2. Durieux AC, Prudhon B, Guicheney P, et al. Dynamin 2 and human diseases. J Mol Med (Berl). 2010 ; 88 (4) : 339–50. [Google Scholar]
  3. Bertrand AT, Chikhaoui K, Ben Yaou R, et al. Laminopathies : un seul gène, de nombreuses pathologies [Laminopathies: one gene, several diseases]. Biol Aujourdhui 2011 ; 205 (3) : 147–62. [Google Scholar]
  4. Feltri ML, Wrabetz L. Laminins and their receptors in Schwann cells and hereditary neuropathies. J Peripher Nerv Syst. 2005 ; 10 (2) : 128–43. [Google Scholar]
  5. Fardeau M, Tomé FM, Helbling-Leclerc A, et al. Dystrophie musculaire congénitale avec déficience en mérosine : analyse clinique,histopathologique, immunocytochimique et génétique [Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis]. Rev Neurol (Paris). 1996 ; 152 (1) : 11–9. [Google Scholar]
  6. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 1995 ; 11 (2) : 216–8. [Google Scholar]
  7. Quijano-Roy S, Renault F, Romero N, et al. EMG and nerve conduction studies in children with congenital muscular dystrophy. Muscle Nerve. 2004 ; 29 (2) : 292–9. [Google Scholar]
  8. Saito Y, Ishiyama A, Saito Y, et al. Myelin abnormalities in merosin-deficient congenital muscular dystrophy. Muscle Nerve 2024 ; 69 (1) : 55–63. [Google Scholar]
  9. Fitzgerald J, Bateman JF. Is there an evolutionary relationship between WARP (von Willebrand factor A-domain-related protein) and the FACIT and FACIT-like collagens? FEBS Lett. 2003 ; 552 (2-3) : 91–4. [Google Scholar]
  10. Pagnamenta AT, Kaiyrzhanov R, Zou Y, et al. An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy. Brain 2021 ; 144 (2) : 584–600. [CrossRef] [PubMed] [Google Scholar]
  11. Ramanoudjame L, Rocancourt C, Lainé J, et al. Two novel COLVI long chains in zebrafish that are essential for muscle development. Hum Mol Genet. 2015 ; 24 (23) : 6624–39. [Google Scholar]
  12. Deschauer M, Hengel H, Rupprich K, et al. Bi-allelic truncating mutations in VWA1 cause neuromyopathy. Brain 2021 ; 144 (2) : 574–583. [CrossRef] [PubMed] [Google Scholar]
  13. Tedesco B, Vendredy L, Timmerman V, et al. The chaperone-assisted selective autophagy complex dynamics and dysfunctions. Autophagy 2023 ; 19 (6) :1619–1641. [Google Scholar]
  14. Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 2019 ; 366 (6467) : 818–822. [Google Scholar]
  15. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet. 2004 ; 36 (6) : 597–601. [Google Scholar]
  16. Ghaoui R, Palmio J, Brewer J, et al. Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy. Neurology 2016 ; 86 (4) : 391–8. [Google Scholar]
  17. Echaniz-Laguna A, Lornage X, Lannes B, et al. HSPB8 haploinsufficiency causes dominant adult-onset axial and distal myopathy. Acta Neuropathol. 2017 ; 134 (1) : 163–165. [Google Scholar]
  18. Rashed HR, Nath SR, Milone M. The Spectrum of Small Heat Shock Protein B8 (HSPB8)-Associated Neuromuscular Disorders. Int J Mol Sci. 2025 ; 26 (7) : 2905. [Google Scholar]
  19. Yang G, Lv X, Yang M, et al. Expanding the spectrum of HSPB8-related myopathy: a novel mutation causing atypical pediatric-onset axial and limb-girdle involvement with autophagy abnormalities and molecular dynamics studies. J Hum Genet. 2025 ; 70 (3) : 159–165. [Google Scholar]
  20. Fernández-Eulate G, Gitiaux C, Thiele S, et al. Disease spectrum and long-term prognosis of patients with BAG3-associated neuromuscular diseases in Europe. Brain 2025 : awaf223. [Google Scholar]
  21. Panos-Basterra P, Theuriet J, Nadaj-Pakleza A, et al. Defining the landscape of TIA1 andSQSTM1 digenic myopathy. Neuromuscul Disord. 2024 ; 42 : 43–52. [Google Scholar]
  22. Bennardini F, Wrzosek A, Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ Res. 1992 ; 71 (2) : 288–94. [Google Scholar]
  23. Thorkelsson A, Chin MT. Role of the Alpha-B-Crystallin Protein in Cardiomyopathic Disease. Int J Mol Sci. 2024 ; 25 (5) : 2826. [Google Scholar]
  24. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann. Neurol. 2003 ; 54 (6) : 804–10. [Google Scholar]
  25. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain. 2004 ; 127 (Pt 2) : 439–51. [Google Scholar]
  26. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998 ; 20 (1) : 925. [Google Scholar]
  27. Cortese A, Currò R, Ronco R, et al. Mutations in alpha-B-crystallin cause autosomal dominant axonal Charcot-Marie-Tooth disease with congenital cataracts. Eur J Neurol. 2024 ; 31 (1) : e16063. [Google Scholar]
  28. Ralston SH, Taylor JP. Rare Inherited forms of Paget’s Disease and Related Syndromes. Calcif Tissue Int. 2019 ; 104 (5) : 501–516. [Google Scholar]
  29. Schiava M, Ikenaga C, Villar-Quiles RN, et al. Genotype-phenotype correlations in valosin-containingprotein disease: a retrospective muticentre study. J Neurol Neurosurg Psychiatry. 2022 , jnnp-2022-328921. [Google Scholar]
  30. Korb MK, Kimonis VE, Mozaffar T. Multisystem proteinopathy: Where myopathy and motor neuron disease converge. Muscle Nerve 2021 ; 63 (4) : 442–454. [Google Scholar]
  31. Stendel C, Neuhofer C, Floride E, et al. Delineating MT-ATP6 associated disease: From isolated neuropathy to early onset neurodegeneration. Neurol Genet. 2020 ; 6 (1) : e393. [Google Scholar]
  32. Rebelo AP, Saade D, Pereira CV, et al. SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency. Brain 2018 ; 141 (3) : 662–672. [Google Scholar]
  33. Rucheton B, Ewenczyk C, Gaignard P, et al. Adult Cerebellar Ataxia, Axonal Neuropathy, and Sensory Impairments Caused by Biallelic SCO2 Variants. Neurol Genet. 2021 ; 7 (6) : e630. [Google Scholar]
  34. Jacquier A, Theuriet J, Fontaine F, et al. Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy. Brain 2023 ; 146 (8) : 3470–3483. [Google Scholar]
  35. Rebelo AP, Tomaselli PJ, Medina J, et al. Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs. Brain 2023 ; 146 (10) : 4191–4199. [Google Scholar]
  36. Freyer C, Stranneheim H, Naess K, et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid. J Med Genet. 2015 ; 52 (11) : 779–83. [Google Scholar]
  37. De Winter J, Van de Vondel L, Ermanoska B, et al. Heterozygous loss-of-function variants in SPTAN1 cause an early childhood onset distal myopathy. Genet Med. 2025 ; 27 (6) : 101399. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.